Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Double Blinded Randomized Multi-Center Controlled Trial Evaluating the 2 Different Doses of Lyophilized Amniotic Fluid Compared to a Saline Placebo Injection in the Treatment of Subjects With Osteoarthritic (OA) Knee Pain

NCT03074526 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Double Blinded Randomized Multi-Center Controlled Trial Evaluating the 2 Different Doses of Lyophilized Amniotic Fluid Compared to a Saline Placebo Injection in the Treatment of Subjects With Osteoarthritic (OA) Knee Pain
Lead sponsor
MiMedx Group, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 23, 2017
Completion date
April 25, 2018
Enrollment
156 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.